MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NYSE |
Shares |
342 M |
Market Cap[1] |
$ 1.54 B |
EBITDA (LTM) |
$ -211 M |
P/E (LTM) |
-11.35 |
P/S (LTM) |
36.976475 |
EPS (LTM) |
-0.6 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Ovid Therapeutics
OVID
|
$ 2.15 | -0.23 % | $ 280 M | Nasdaq Global Select Market | USA |
 |
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | USA |
 |
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE |  Israel |
 |
Puma Biotechnology
PBYI
|
$ 10.85 | -1.54 % | $ 543 M | Nasdaq Global Select Market | USA |
 |
Processa Pharmaceuticals
PCSA
|
$ 1.76 | -2.76 % | $ 2.3 M | Nasdaq Global Select Market | USA |
 |
Vaxcyte
PCVX
|
$ 59.95 | -0.79 % | $ 8.16 B | Nasdaq Global Select Market | USA |
 |
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Pfizer
PFE
|
$ 29.8 | -0.78 % | $ 169 B | NYSE,SPB | USA |
 |
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market |  Irlanda |
 |
Pharming Group N.V.
PHAR
|
$ 11.85 | 5.8 % | $ 8.16 B | Nasdaq Global Select Market |  Niderland |
|
Phathom Pharmaceuticals
PHAT
|
$ 5.94 | 3.48 % | $ 433 M | Nasdaq Global Select Market,SPB | USA |
 |
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.87 | 2.04 % | $ 5.21 M | Nasdaq Capital Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.6 | -5.34 % | $ 6.54 M | Nasdaq Global Select Market | USA |
 |
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | USA |
 |
Pliant Therapeutics
PLRX
|
$ 0.85 | -1.64 % | $ 52.2 M | Nasdaq Global Select Market | USA |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Unity Biotechnology
UBX
|
- | -33.41 % | $ 3.37 M | Nasdaq Global Select Market | USA |
 |
Praxis Precision Medicines
PRAX
|
$ 267.68 | 5.82 % | $ 6.02 B | Nasdaq Global Select Market,SPB | USA |
 |
PainReform Ltd.
PRFX
|
$ 0.74 | 0.07 % | $ 480 K | Nasdaq Capital Market | Israel |
 |
Prelude Therapeutics Incorporated
PRLD
|
$ 3.69 | 1.65 % | $ 284 M | Nasdaq Global Select Market | USA |
 |
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | USA |
 |
ProQR Therapeutics N.V.
PRQR
|
$ 1.23 | -4.65 % | $ 130 M | Nasdaq Global Market | Niderland |
 |
Prothena Corporation plc
PRTA
|
$ 8.38 | 2.2 % | $ 451 M | Nasdaq Global Select Market,SPB | USA |
 |
PTC Therapeutics
PTCT
|
$ 61.04 | 0.74 % | $ 4.85 B | Nasdaq Global Select Market,SPB | USA |
 |
Protagonist Therapeutics
PTGX
|
$ 140.24 | 1.31 % | $ 8.92 B | Nasdaq Global Select Market | USA |
 |
Pulmatrix
PULM
|
$ 1.44 | -2.7 % | $ 5.26 B | Nasdaq Global Select Market | USA |
 |
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Atossa Therapeutics
ATOS
|
$ 2.45 | -5.91 % | $ 21.1 M | Nasdaq Capital Market | USA |
 |
Ultragenyx Pharmaceutical
RARE
|
$ 16.09 | 2.78 % | $ 1.59 B | Nasdaq Global Select Market,SPB | USA |
 |
Arcus Biosciences
RCUS
|
$ 17.7 | -4.53 % | $ 1.9 B | NYSE,SPB | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.43 | 0.57 % | $ 5.3 B | Nasdaq Global Market | Israel |
 |
Regeneron Pharmaceuticals
REGN
|
$ 808.08 | 0.38 % | $ 84.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Replimune Group
REPL
|
$ 12.48 | 8.9 % | $ 1.16 B | Nasdaq Global Select Market | USA |
 |
Galmed Pharmaceuticals Ltd.
GLMD
|
$ 4.63 | 21.05 % | $ 20 M | Nasdaq Capital Market | Israel |
 |
Rafael Holdings
RFL
|
$ 1.18 | -9.92 % | $ 34.7 M | NYSE | USA |
 |
REGENXBIO
RGNX
|
$ 6.58 | -1.5 % | $ 339 M | Nasdaq Global Select Market,SPB | USA |
 |
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | USA |
 |
Rigel Pharmaceuticals
RIGL
|
$ 49.95 | 3.78 % | $ 898 M | Nasdaq Global Select Market | USA |
 |
Compugen Ltd.
CGEN
|
$ 1.89 | -2.84 % | $ 177 M | Nasdaq Global Market,SPB | Israel |
 |
Relay Therapeutics
RLAY
|
$ 18.16 | -0.11 % | $ 3.12 B | Nasdaq Global Market | USA |
 |
Coherus BioSciences
CHRS
|
$ 1.0 | -0.5 % | $ 117 M | Nasdaq Global Market | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
Royalty Pharma plc
RPRX
|
$ 64.76 | 1.4 % | $ 27.8 B | Nasdaq Global Select Market | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 89.56 | 0.32 % | $ 5.82 B | Nasdaq Global Market,SPB | USA |
|
Rezolute
RZLT
|
$ 3.82 | -1.04 % | $ 397 M | Nasdaq Capital Market | USA |
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.